Shares of Provention Bio soared Monday after the biopharmaceutical company agreed to be acquired by France’s Sanofi (SNY) for $25 a share, or about $2.9 billion. Provention Bio (ticker: PRVB), which f...
Tag: SAN.FR
First Republic, Provention Bio, Roku, Illumina, Boeing, and More Market Movers
This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com. https://www.barro...
The Big Winners—and Losers —in the Inflation Bill
Senate Majority Leader Chuck Schumer (D-NY) helped shepherd the Inflation Reduction Act through the Senate after earlier bills died. Drew Angerer/Getty Images Text size The House won’t take up Democra...
Covid-19 Vaccine Makers Face a New Rival as GlaxoSmithKline and Sanofi Prepare to Enter the Ring
As new Covid-19 cases fall, the postpandemic vaccine market grows more interesting. On Wednesday, GlaxoSmithKline and Sanofi, two of the world’s largest vaccine makers, said they would submit a Covid ...
Moderna Shipped 800 Million Covid-19 Vaccine Doses in 2021
Text size Syringes with Moderna’s Covid-19 vaccine. Thomas Lohnes/Getty Images Moderna said in a letter to shareholders on Tuesday that it had shipped approximately 800 million doses of its Covi...
Moderna Faces Challenges Beyond the Covid Vaccine. Its Stock Is Still a Buy for the Long Term.
In 2019, four pharmaceutical giants shared virtually all of the $33 billion worth of vaccine revenue earned worldwide. The pandemic has upended the vaccine business. Moderna has sold or contracted to ...